To test the hypothesis that CYP26C1 is a modifier of SHOX deficiency, we tested different concentration of shox and cyp26c1 MOs to determine subphenotypic dosages. Here, SHOX is linked to hyperinsulinemic hypoglycemia, familial, 4.